Boston Children's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT02831348
This is a pilot cross-sectional study of measured transcutaneous CO-oximetry in children with inflammatory and non-inflammatory conditions.
Looking for future studies?
Notify Me6 year–24 year
All sexes
Observational
Boston, Massachusetts, 02115, United States
Children and young adults age 6-24 with the following conditions: asthma, pneumonia, allergic rhinitis, cystic fibrosis, and well child (without inflammatory illness) will be recruited.
Subjects will be asked to complete a brief screening survey to determine if they meet inclusion criteria. Enrolled subjects will be asked to complete questionnaire forms to characterize their health, current symptoms, medications, and common exposures. Transcutaneous carboxyhemoglobin will be recorded.
This study is cross-sectional and will only require one visit coinciding with the clinical visit. Analysis will determine the pairwise differences in SpCO between conditions tested.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Time of visit
A pairwise comparison of mean SpCO will be performed between asthma exacerbation group and each other group, e.g., asthma exacerbation v. stable asthma, asthma exacerbation v. pneumonia, etc. An independent t-test will be used to determine statistical significance of the difference of means.
Boston Children's Hospital
Other
Acronym: COOX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04476433
Abnormalities, Multiple, Allergic Asthma
Valencia, Spain
View Trial DetailsNCT04239521
Acute Bronchitis, Allergic Rhinitis
London, United Kingdom
View Trial DetailsNCT03509766
Allergic Rhinitis, Asthma
Baltimore, Maryland, United States
View Trial DetailsNCT03599908
Allergic Rhinitis, Asthma
View Trial Details